• Affymax, Inc. (AFFY) and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Release: OMONTYS® (Peginesatide) Injection Now Available for Adult Chronic Kidney Disease (CKD) Patients on Dialysis in the United States More...

• Mylan Inc. (MYL) Launches Generic Version of Zyprexa® Tablets More...

• Vertex Pharmaceuticals (MA) (VRTX) Release: INCIVEK™ (telaprevir) Now Funded for People With Hepatitis C in Quebec and Saskatchewan More...

• Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Olanzapine Tablets More...

• Ikaria Inc.'s LUCASSIN® Approved in Australia More...

• Alimera Sciences (ALIM) Release: ILUVIEN® Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema More...

• Biogen Idec, Inc. (Massachusetts) (BIIB) Says Phase III Data Highlight Safety Profile For BG-12 MS Drug; Stock Rises +Up 2.14(1.70%) @ 1:22PM EDT More...

• Sosei Group Corporation's QVA149 ILLUMINATE Phase III COPD Study Meets Primary Endpoint and Clarification of Anticipated Timing of US Filings for NVA237 and QVA149 More...

• Nordion International Announces Europe-Focused Phase III Clinical Trial for TheraSphere® Liver Cancer Treatment More...

• RedHill Biopharma Ltd. Commences a Pivotal Bioequivalence Trial with RHB-103 (An Oral Thin Film for the Treatment of Migraine); Subjects' Recruitment Completed; First Dose Administered; Results Expected within Months More...

• Coronado Biosciences Announces Independent Data Monitoring Committee Recommendation to Continue Falk Phase 2 Trial of TSO in Crohn's Disease More...

• Evidence Behind Autism Drugs May Be Biased, University of Michigan Study More...

• Could Caffeine Help Dry Eye? University of Tokyo School of Medicine Study More...

• How to Look Good on Facebook, University of Twente Study More...

• PURE Bioscience (PURE) Announces Positive Research from University of Arkansas More...

• Advanced Cell Technology Announces Data and Safety Monitoring Board (DSMB) Approval to Increase RPE Dosage for Stargardt's Disease Patients in U.S. Trial More...

• NewLink Genetics Receives Notice of Allowance From USPTO for New Patent Broadly Covering Its D-1MT IDO Pathway Inhibitor More...

• MediciNova, Inc. Receives Notice of an Australian Patent Allowance for a Method of Treating Neuropathic Pain More...

• Merck KGaA (MKGAF.PK) Slashes 580 Jobs Amid Swiss HQs Shutdown More...

• Unipharma to Add 44 Jobs in New York More...

• Argos Therapeutics, Inc. Raises $25 Million Series D Financing More...

• miRagen Therapeutics Secures $20 Million Series B Financing More...

• Watson Pharmaceuticals, Inc. (WPI) May Pay $6 Billion Actavis More...

• Bausch & Lomb and ISTA Pharmaceuticals, Inc. (ISTA) Announce Early Termination of Hart-Scott-Rodino Waiting Period More...

• IMS Health (RX) Expands Services in Pharma R&D With Acquisition of DecisionView More...

• US Clinical Laboratories Announces Houston Acquisition More...

• Bayer AG (BAY.F) to Develop Cancer Treatment With Amgen (AMGN) More...

• ARTES Biotechnology Announces a Strategic Collaboration Deal for Vaccine Development More...

• Sandoz, Inc. Enters Local Cameroon Production Partnership to Increase Access to Quality Medicines in Sub-Saharan Africa More...

• Northwest Biotherapeutics (NWBT) and Fraunhofer IZI Announce Milestones Reached More...

• Cerus Corporation (CERS) and New York Blood Center to Collaborate on Development of Novel Red Blood Cell Biologic Product with Improved Uniformity More...

• Amgen (AMGN) Founding CEO George Rathmann Dies More...

• The New Amgen (AMGN) CEO and the Challenges He Faces, Must Win Investors With Payouts, Deals: Analysts More...

• S1 Pharmaceuticals, Inc. Announces New Executive Management and Scientific Advisory Board Appointments More...

• BioScrip (BIOS) Appoints Hai V. Tran as Senior Vice President, Chief Financial Officer and Treasurer More...

• miRagen Therapeutics Expands Executive Team Adding Drug Development Veteran More...

• Novartis AG (NVS) Quarterly Profit Drops as Diovan, OTC Sales Slump More...

• Alexion Pharmaceuticals Inc. (ALXN) Reports First Quarter 2012 Results More...

• Array BioPharma, Inc. (ARRY) to Report Financial Results for the Third Quarter of Fiscal 2012 on April 30, 2012 More...
• Astex Pharmaceuticals (ASTX) to Announce 2012 First Quarter Financial Results on April 30, 2012 More...
• Aegerion Pharmaceuticals, Inc. to Announce First Quarter 2012 Financial Results on Tuesday, May 1 More...
More Earnings Report News




• The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in NeurogesX, Inc. (NGSX) of Class Action Lawsuit More...
More Legal News




• Life Technologies (LIFE) to Build Additional $20 Million State of the Art Cell Culture Facility in Scotland More...
• AAIPharma Services Opens New Technology Center More...
• PsiOxus Therapeutics Limited Moves into New Facilities on Milton Park to Accommodate Expansion More...